Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Search
Subscribe
Home
Contact Us
Subscription Services
Promote Your Event
e-Edition
News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Place an Ad
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Apyx Medical Corporation
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction
February 01, 2023
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
January 10, 2023
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
November 10, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022
September 26, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference
September 06, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
August 11, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet
July 27, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin
July 18, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region
July 08, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
June 30, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures
May 26, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June
May 25, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
May 12, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
April 04, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin
April 04, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook
March 17, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Notified of Pending FDA Medical Device Safety Communication Related to its Advanced Energy Products
March 14, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures
February 17, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022
January 27, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results
January 10, 2022
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
November 11, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December
November 10, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2021 Financial Results on November 11, 2021
October 04, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference
September 01, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company’s Board of Directors
August 30, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
August 12, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
July 12, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
June 03, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures
June 01, 2021
From
Apyx Medical Corporation
Via
Business Wire
Tickers
APYX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.